Pegaspargase
Drug timelines are a Plus or Pro feature.
32 regulatory and trial events tracked for Pegaspargase, covering 2012-09-12 to 2026-04-13. Get the full timeline:
Most recent: Clinical Trial Update: Combination of Mitoxantrone Liposome and Etoposide, Dexamethasone, Pegaspargase and Golidocitinib (MEPL-G) in the Treatment of NK/T-cell Lymphoma Associated Hemophagocytic Lymphohistiocytosis (NKTCL-HLH) [Phase 1, Phase 2]